Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(21 sites)
China
The Second Xiangya Hospital of Central South University, Changsha Zhejiang Provincial People's Hospital, Hangzhou The Fourth Affiliated Hospital of Harbin Medical University, Ha’erbin Huai 'an First People's Hospital, Huai'an Liaocheng People's Hospital, Liaocheng Jiangxi Provincial People's Hospital, Nanchang Jiangsu Geriatric Hospital, Nanjin The First Hospital of Ningbo, Ningbo The Sixth Hospital of Ningbo, Ningbo Pingxiang People's Hospital, Pingxiang Huadong Hospital Affiliated to Fudan University, Shanghai Shanghai First People's Hospital, Shanghai Shanghai Pudong New Area Punan Hospital, Shanghai Shanghai Sixth People's Hospital, Shanghai Zhongshan Hosiptal Affiliated to Fudan University, Shanghai The Second Affiliated Hospital of Soochow University, Suzhou The First Hospital of Shanxi Medical University, Taiyuan The Second Hospital of Shanxi Medical University, Taiyuan Tianjin Hospital, Tianjin Xi'an Honghui Hospital, Xi'an Xuzhou Central Hospital, Xuzhou